Related references
Note: Only part of the references are listed.Lysophosphatidic Acid and Autotaxin-associated Effects on the Initiation and Progression of Colorectal Cancer
C. Chris Yun
CANCERS (2019)
Recent developments with immunotherapy for hepatocellular carcinoma
Oliver Waidmann
EXPERT OPINION ON BIOLOGICAL THERAPY (2018)
Ramucirumab as Second-Line Systemic Therapy in Hepatocellular Carcinoma
Masatoshi Kudo
LIVER CANCER (2018)
Systemic Therapy for Hepatocellular Carcinoma: Latest Advances
Masatoshi Kudo
CANCERS (2018)
Hepatocyte Autotaxin Expression Promotes Liver Fibrosis and Cancer
Eleanna Kaffe et al.
HEPATOLOGY (2017)
Acute liver failure caused by pembrolizumab in a patient with pulmonary metastatic liver cancer: A case report
Zhenping Wu et al.
MEDICINE (2017)
Mitochondrial respiratory gene expression is suppressed in many cancers
Ed Reznik et al.
ELIFE (2017)
Lysophosphatidic acid (LPA) signaling via LPA4 and LPA6 negatively regulates cell motile activities of colon cancer cells
Kaede Takahashi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition
Shigeki Nakagawa et al.
CANCER CELL (2016)
p21(WAF1) Mediates Cell-Cycle Inhibition, Relevant to Cancer Suppression and Therapy
Wafik S. El-Deiry
CANCER RESEARCH (2016)
Cyclin D1, cancer progression, and opportunities in cancer treatment
Shuo Qie et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
Phosphatases and kinases regulating CDC25 activity in the cell cycle: clinical implications of CDC25 overexpression and potential treatment strategies
Swastika Sur et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2016)
Mitochondrial DNA copy number variation across human cancers
Ed Reznik et al.
ELIFE (2016)
Higher LPA2 and LPA6 mRNA Levels in Hepatocellular Carcinoma Are Associated with Poorer Differentiation, Microvascular Invasion and Earlier Recurrence with Higher Serum Autotaxin Levels
Kenichiro Enooku et al.
PLOS ONE (2016)
Lysophosphatidic Acid Receptor LPAR6 Supports the Tumorigenicity of Hepatocellular Carcinoma
Antonio Mazzocca et al.
CANCER RESEARCH (2015)
LPP3 localizes LPA6 signalling to non-contact sites in endothelial cells
Hiroshi Yukiura et al.
JOURNAL OF CELL SCIENCE (2015)
Targeting Cdc20 as a novel cancer therapeutic strategy
Lixia Wang et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Pro-apoptotic Sorafenib signaling in murine hepatocytes depends on malignancy and is associated with PUMA expression in vitro and in vivo
R. Sonntag et al.
CELL DEATH & DISEASE (2014)
Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma
Eugene Sokolov et al.
JOURNAL OF SURGICAL RESEARCH (2013)
Management of HCC
Carlos Rodriguez de Lope et al.
JOURNAL OF HEPATOLOGY (2012)
TGFα shedding assay: an accurate and versatile method for detecting GPCR activation
Asuka Inoue et al.
NATURE METHODS (2012)
Tumor-Secreted Lysophostatidic Acid Accelerates Hepatocellular Carcinoma Progression by Promoting Differentiation of Peritumoral Fibroblasts in Myofibroblasts
Antonio Mazzocca et al.
HEPATOLOGY (2011)
Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D
Swadesh K. Das et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2008)
Coordination of mitochondrial bioenergetics with G1 phase cell cycle progression
Stefan M. Schieke et al.
CELL CYCLE (2008)
Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma
HC Lee et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2004)
Share Paper
